Over the past year, the Food and Drug Administration has recalled multiple blood pressure medications after discovering a potentially cancer-causing contaminant in some batches. It’s believed they became contaminated during the manufacturing process. The recalled medications include specific “lots” of losartan, irbesartan, valsartran and combination drugs with valsartran. The investigation is ongoing and the FDA… Read More »
(Reuters) – A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity, according to the U.S. Food and Drug Administration. The impurity N-Nitrosodiethylamine (NDEA) was detected in quantities above the acceptable limit in certain tablets… Read More »
A Food and Drug Administration recall of a heart medication due to a cancer-causing chemical now includes two blood pressure medications. Teva Pharmaceuticals has issued a voluntary recall of its amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets, both used to treat high blood pressure, according to the FDA. The FDA announced the recall on its… Read More »
The recalled lot will have “Westminster Pharmaceuticals” and “GSMS Inc.” on the label, according to the FDA list. Another heart medicine, valsartan, has also been recalled recently due to contamination. Irbesartan is an angiotensin II receptor blocker, or ARB. This is a drug that blocks a potent chemical in the blood called anigiotensin, which causes… Read More »